Skip to content
Open access · CC-BY via OpenAlex

Unveiling the Interplay of EBV, HSV-1, and Inflammatory Biomarkers in Psychiatric Disorders

Özer Akgül, Ömer Faruk Demirel, İlker Tosun, Yasin Kavla, Mehmet Murat Kırpınar, Burcu Sapmaz, Gülçin Şenyiğit, Reyhan Çalışkan, Yaşar Ali Öner

Journal of Clinical Medicine · 2025 · ▲ 2 citations

Abstract

Background/Objectives: Schizophrenia (SCH), bipolar disorder (BPD), and major depressive disorder (MDD) are increasingly viewed as neuroimmune disorders shaped by viral exposure and inflammation. Disorder-specific immunovirological profiles, however, remain poorly defined. Methods: In this cross-sectional study, we assessed Epstein–Barr Virus (EBV) and Herpes Simplex Virus type 1 (HSV-1) seropositivity and measured serum CRP, IL-6, and IL-1β in 708 participants: 110 with SCH, 121 with BPD, 135 with MDD, and 342 healthy controls (HC). Statistical analyses included Shapiro–Wilk tests for normality; Kruskal–Wallis with Bonferroni-adjusted Dunn post hoc comparisons; and logistic regression adjusted for age, sex, and marital status. Results: EBV seropositivity was higher in SCH (90.9%) than in HC (78.9%) (OR = 3.46, 95% CI: 1.68–7.12; p = 0.001) but not in BPD or MDD. HSV-1 seropositivity was elevated in BPD (83.5%) versus HC (67.0%) (OR = 2.29, 95% CI: 1.34–3.92; p = 0.003), with no differences in SCH or MDD. Inflammatory biomarkers were significantly increased in SCH and MDD compared to HC (p < 0.001), while BPD showed no differences. Conclusions: The findings delineate distinct immunovirological patterns across major psychiatric disorders. Schizophrenia was characterized by EBV seropositivity accompanied by systemic inflammatory activation, bipolar disorder by HSV-1 seropositivity in the absence of inflammatory changes, and major depressive disorder by inflammatory dysregulation independent of viral exposure. These disorder-specific profiles highlight heterogeneity in neuroimmune pathways and underscore the potential relevance of biomarker-based stratification for generating hypotheses regarding targeted antiviral or anti-inflammatory interventions in psychiatric populations.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/jcm14196730
Canonical
link ↗
Fetched
2026-10-16 MST

Cite this

APA
Akgül, �., Demirel, �.F., Tosun, �., Kavla, Y., Kırpınar, M.M., Sapmaz, B., Şenyiğit, G., Çalışkan, R., &amp; Öner, Y.A. (2025). Unveiling the Interplay of EBV, HSV-1, and Inflammatory Biomarkers in Psychiatric Disorders. <em>Journal of Clinical Medicine</em>. https://doi.org/10.3390/jcm14196730
Vancouver
Akgül �, Demirel �F, Tosun �, Kavla Y, Kırpınar MM, Sapmaz B, et al. Unveiling the Interplay of EBV, HSV-1, and Inflammatory Biomarkers in Psychiatric Disorders. Journal of Clinical Medicine. 2025. doi:10.3390/jcm14196730.
BibTeX
@article{zer2025Unveil, title = {Unveiling the Interplay of EBV, HSV-1, and Inflammatory Biomarkers in Psychiatric Disorders}, author = {Özer Akgül and Ömer Faruk Demirel and İlker Tosun and Yasin Kavla and Mehmet Murat Kırpınar and Burcu Sapmaz and Gülçin Şenyiğit and Reyhan Çalışkan and Yaşar Ali Öner}, journal = {Journal of Clinical Medicine}, year = {2025}, doi = {10.3390/jcm14196730}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings